Idalopirdine
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Idalopirdine, covering 2015-05-07 to 2018-08-10. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease [Phase 3]